EN
HI
Summary
As of 11 Sep, 2026, Jenburkt Pharmaceuticals stock price is ₹1025. During the trading session, the stock has moved between an intraday low of ₹1017.60 and an intraday high of ₹1029.00. Over the last 52 weeks, Jenburkt Pharmaceuticals has traded between ₹1000.00 and ₹1073.90.
The stock has recorded a trading volume of 64 shares,. Its Average Traded Price (ATP) is ₹1018.99, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1025.00.
Jenburkt Pharmaceuticals has an upper circuit limit of ₹1232.10 and a lower circuit limit of ₹821.50. The total value traded stands at ₹65215.36, and the delivery percentage for the day is 83.19%.
The stock is currently traded with a market lot size of 1. Jenburkt Pharmaceuticals also offers a dividend yield of 0%.
Jenburkt Pharmaceuticals Share Price Chart
Jenburkt Pharmaceuticals Share Key Metrics
Volume
64.00
Market Cap
453.16 CR
LTQ@LTP
1@1025.00
ATP
1018.99
Var Margin
17.59 %
Circuit Range
821.5-1232.1
Delivery %
83.19 %
Value
65215.36
ASM/GSM
No
Market Lot
1
Jenburkt Pharmaceuticals Resistance and Support
Pivot 1024.6
Resistance
First Resistance
1049.2
Second Resistance
1071.6
Third Resistance
1096.2
Support
First Support
1002.2
Second Support
977.6
Third Support
955.2
Jenburkt Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 1020 | 1025 | -0.18% | 1029 | 1017.6 |
| Thu Sep 10 2026 | 1026.59 | 1026.8 | 0.30% | 1047 | 1000 |
| Wed Sep 09 2026 | 1052.5 | 1023.7 | -1.56% | 1052.9 | 1021.2 |
Jenburkt Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Jenburkt Pharmaceuticals News
Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Directorate
Jenburkt Pharmaceuticals shareholders have approved the re-appointment of Shri Dilip H. Bhuta as Whole Time Director and Chief Financial Officer for a period of five years. His term will commence from April 1, 2027, and conclude on March 31, 2032.
Sep 04 2026 21:34:03
Jenburkt Pharmaceuticals Ltd - 524731 - Proceedings Of The 41St Annual General Meeting Of The Company Held On Friday, 04Th September, 2026.
Jenburkt Pharmaceuticals held its 41st Annual General Meeting on September 4, 2026. Shareholders approved the FY26 audited financial statements, declared a 207% dividend (Rs. 20.70 per share), and re-appointed Shri Dilip H. Bhuta as Whole-Time Director and CFO.
Sep 04 2026 20:40:29
Jenburkt Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish U Bhuta | Chairman & Managing Director |
| Dilip H Bhuta | Whole Time Director & Chief Financial Officer |
Jenburkt Pharmaceuticals FAQs
The Buying Price of Jenburkt Pharmaceuticals share is 1025 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jenburkt Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jenburkt Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jenburkt Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jenburkt Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jenburkt Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.56 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jenburkt Pharmaceuticals is 453.16 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jenburkt Pharmaceuticals share price is 1073.90 & 1000.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jenburkt Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JENBURPH
